Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Accounts Payables (2020 - 2025)

KORU Medical Systems has reported Accounts Payables over the past 10 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Accounts Payables at $2.3 million for Q4 2025, up 37.43% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (up 37.43% YoY), and the annual figure for FY2025 was $2.3 million, up 37.43%.
  • Accounts Payables for Q4 2025 was $2.3 million at KORU Medical Systems, up from $1.9 million in the prior quarter.
  • Over the last five years, Accounts Payables for KRMD hit a ceiling of $2.4 million in Q4 2022 and a floor of $945619.0 in Q3 2023.
  • Median Accounts Payables over the past 5 years was $1.6 million (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Accounts Payables: surged 137.64% in 2022 and later plummeted 59.23% in 2023.
  • KORU Medical Systems' Accounts Payables stood at $1.2 million in 2021, then surged by 94.85% to $2.4 million in 2022, then plummeted by 59.23% to $975193.0 in 2023, then surged by 69.19% to $1.6 million in 2024, then surged by 37.43% to $2.3 million in 2025.
  • The last three reported values for Accounts Payables were $2.3 million (Q4 2025), $1.9 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.